Some thoughts about stock market risk…

by Crista Huff The following is an excerpt from this week’s issue of Cabot Undervalued Stocks Advisor:   When I’m out and about in the world, talking to investors, I’ve noticed that when I mention my goal of minimizing the risk associated with stock investing, people’s eyes glaze over. I’ve come...

Goodfellow LLC Stock Portfolio Update — March 17, 2017

  For five straight years through 2016, the Goodfellow LLC model equity portfolios outperformed the S&P 500 and/or the Dow Jones Industrial Average!   Goodfellow LLC Portfolio                                 Gain/ & Market Index Performance                          (Loss)   2017...

The Writing Was On the Wall with Valeant Pharmaceuticals, and Bill Ackman Willfully Ignored It

by Crista Huff     Finally, famed hedge fund manager Bill Ackman, CEO of Pershing Square Capital Management, is selling his shares in Valeant Pharmaceuticals (VRX). I hear he lost over $2.8 billion. Ouch. I’d say something like “a day late and a dollar short”, but the situation...

Goodfellow LLC Stock Portfolio Update — March 10, 2017

  For five straight years through 2016, the Goodfellow LLC model equity portfolios outperformed the S&P 500 and/or the Dow Jones Industrial Average!   Goodfellow LLC Portfolio                                 Gain/ & Market Index Performance                          (Loss)   2017...

Goodfellow LLC Stock Portfolio Update — March 3, 2017

  (Scroll toward my signature, below, to read more about the calculation of portfolio performance. Thank you.)   For five straight years through 2016, the Goodfellow LLC model equity portfolios outperformed the S&P 500 and/or the Dow Jones Industrial Average!   Goodfellow LLC Portfolio  ...

« Older Entries